OnAsset Intelligence
Global Real Time Tracking and Monitoring Solutions for Clinical trials
Immuno-oncology imaging firm ImaginAb has started patient enrolment in a Phase II clinical trial of its CD8 tracer 89Zr-Df-IAB22M2C to visualise T-cells and enable personalised treatment.
Immuno-oncology imaging firm ImaginAb has started patient enrolment in a Phase II clinical trial of its CD8 tracer 89Zr-Df-IAB22M2C to visualise T-cells and enable personalised treatment.
The first patient has been enrolled at City of Hope, a research and treatment centre in Los Angeles County, California, US.
89Zr-Df-IAB22M2C is an imaging agent that uses non-invasive, whole-body in-vivo PET imaging of CD8 T cells to visualise the immune system.
The technology leverages ImaginAb’s Minibody platform to target and visualise CD8+ T-cells to offer specific and quantitative assessment of the immunological status of each cancer lesion in a patient.
This approach is expected to facilitate tailored treatment based on the needs of individual patients.
ImaginAb CEO Ian Wilson said: “ImaginAb’s goal is to provide target-specific imaging agents to predict, inform, monitor and enable treatment of cancer disease more effectively.”
City of Hope expands the ImaginAb active sites performing Phase II baseline / on-treatment trials to evaluate the use of 89Zr-Df-IAB22M2C.
During the trial, the PET tracer’s utility in imaging CD8 T cells before (baseline) and after (on-treatment) cancer patients undergo immunotherapy-based treatment will be investigated.
Metastatic cancer patients will be recruited into the trial, which will explore the link between imaging signals observed using ImaginAb’s ImmunoPET imaging agent, standard-of-care scans and also immunohistochemistry analysis of CD8 in biopsied tissues.
The study will also measure changes in CD8+ T-cell distribution prior to and after immuno-oncology therapies.
ImaginAb is developing a pipeline of in-vivo antibody-based imaging agents to drive the development of therapeutic antibodies, diagnose disease, and aid precision medicine.
Global Real Time Tracking and Monitoring Solutions for Clinical trials
Software Solutions for Clinical Trial and Medical Research Project Management
Cloud-Based Off-the-Shelf Clinical Metadata Repository and Clinical Trial Automation Software Platform